Trials / Completed
CompletedNCT04420078
Brugada Ablation of VF Substrate Ongoing MultiCenter Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 159 (actual)
- Sponsor
- Pacific Rim Electrophysiology Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.
Detailed description
Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators exclude patients who were lost to follow up in the outpatient clinic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Catheter Ablation | Ventricular fibrillation substrate |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2022-02-28
- Completion
- 2023-12-01
- First posted
- 2020-06-09
- Last updated
- 2024-11-21
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT04420078. Inclusion in this directory is not an endorsement.